Previous Chapter: 6 Design Considerations: Recruitment and Retention
Suggested Citation: "7 Site Preparedness." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 160
Suggested Citation: "7 Site Preparedness." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 161
Suggested Citation: "7 Site Preparedness." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 162
Suggested Citation: "7 Site Preparedness." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 163
Suggested Citation: "7 Site Preparedness." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 164
Suggested Citation: "7 Site Preparedness." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 165
Suggested Citation: "7 Site Preparedness." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 166
Suggested Citation: "7 Site Preparedness." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 167
Suggested Citation: "7 Site Preparedness." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 168
Suggested Citation: "7 Site Preparedness." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 169
Suggested Citation: "7 Site Preparedness." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 170
Suggested Citation: "7 Site Preparedness." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 171
Suggested Citation: "7 Site Preparedness." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 172
Suggested Citation: "7 Site Preparedness." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 173
Suggested Citation: "7 Site Preparedness." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 174
Next Chapter: 8 Estimating HIV Incidence
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.